(isatuximab) Phase 3 trial met primary endpoint of progression free survival in patie | IMGN Message Board Posts


IMGN   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  57276 of 57658  at  12/7/2023 2:21:13 PM  by

wal187lco


 In response to msg 57275 by  GaryM
view thread

Re: (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patie

I would think with all the Abbvie m&a activity it would make an outside bid more likely for us. They know Abbvie won’t have the stomach to chase Imgn very far with all the money that is going out the door.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 0  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
57278 Re: (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patie GaryM 0 12/7/2023 2:29:18 PM




Financial Market Data provided by
.
Loading...